Avricore Health (AVCRF) Net Cash Flow (2014 - 2025)
Avricore Health (AVCRF) reported Net Cash Flow of -$436061.7 for Q3 2025, down 218.03% year-over-year from $369454.5 in Q3 2024, and down 118.57% quarter-over-quarter from -$199507.3 in Q2 2025.
Avricore Health (AVCRF) Net Cash Flow (2014 - 2025) Analysis & Trends
Avricore Health (AVCRF) has 12 years of Net Cash Flow data on file, last reported at -$436061.7 in Q3 2025.
- Net Cash Flow for Q3 2025 came in at -$436061.7, down 218.03% year-over-year; the trailing twelve-month figure through Dec 2025 was -$540044.0 (down 167.37% YoY), and the FY2025 annual result was -$647223.3, down 203.53% from the prior year.
- Net Cash Flow declined to -$436061.7 in Q3 2025 per AVCRF's latest filing, from -$199507.3 in the prior quarter.
- Over five years, Net Cash Flow peaked at $1.8 million in Q1 2021 and troughed at -$441164.3 in Q3 2022.
- A 5-year average of $15532.5 and a median of -$81345.1 in 2023 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2024: Net Cash Flow sank 740.12% in 2022, then surged 778.58% in 2024.
- A 5-year view of Net Cash Flow shows it stood at -$167766.8 in 2021, then decreased by 9.17% to -$183145.8 in 2022, then jumped by 54.7% to -$82973.1 in 2023, then soared by 545.27% to $369454.5 in 2024, then sank by 218.03% to -$436061.7 in 2025.
- Business Quant data shows AVCRF's Net Cash Flow at -$436061.7 in Q3 2025, -$199507.3 in Q2 2025, and $95524.9 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -121.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -6.68 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.12 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 21.27 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 56.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 11.79 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -11.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -328.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -5.89 Mn |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -436,061.66 |
| Sep 30, 2025 | -436,061.66 |
| Jun 30, 2025 | -199,507.32 |
| Jun 30, 2025 | -199,507.32 |
| Mar 31, 2025 | 95,524.95 |
| Mar 31, 2025 | 95,524.95 |
| Sep 30, 2024 | 369,454.52 |
| Sep 30, 2024 | 369,454.52 |
| Jun 30, 2024 | 204,016.73 |
| Jun 30, 2024 | 204,016.73 |
| Mar 31, 2024 | 228,177.55 |
| Mar 31, 2024 | 228,177.55 |
| Dec 31, 2023 | -82,973.13 |
| Dec 31, 2023 | -82,973.13 |
| Sep 30, 2023 | -61,792.88 |
| Sep 30, 2023 | -61,792.88 |
| Jun 30, 2023 | -30,065.46 |
| Jun 30, 2023 | -30,065.46 |
| Mar 31, 2023 | -79,717.08 |
| Mar 31, 2023 | -79,717.08 |